Peter J. Snyder

Endocrinology

3400 Civic Center Boulevard
South Pavilion, 2nd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Testosterone for Middle-Aged and Older Men with Hypogonadism. Reply.

Testosterone for Middle-Aged and Older Men with Hypogonadism. Reply.

Journal: The New England journal of medicine

Published: November 05, 2025

Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism.

Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism.

Journal: The New England journal of medicine

Published: August 06, 2025

Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment.

Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment.

Journal: The Journal of clinical endocrinology and metabolism

Published: June 23, 2025

Depressive Symptoms and Amyloid Pathology.

Depressive Symptoms and Amyloid Pathology.

Journal: JAMA psychiatry

Published: January 22, 2025

Proceedings of the 2024 Santa Fe Bone Symposium: Update on the Management of Osteoporosis and Rare Bone Diseases.

Proceedings of the 2024 Santa Fe Bone Symposium: Update on the Management of Osteoporosis and Rare Bone Diseases.

Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry

Published: October 17, 2024

Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4).

Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4).

Journal: Endocrine journal

Published: August 25, 2024

Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.

Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 21, 2024

Modulation of circulating free testosterone fraction by testosterone, dihydrotestosterone, and estradiol during testosterone replacement therapy.

Modulation of circulating free testosterone fraction by testosterone, dihydrotestosterone, and estradiol during testosterone replacement therapy.

Journal: Andrology

Published: May 21, 2024

Testosterone Treatment and Fractures in Men with Hypogonadism. Reply.

Testosterone Treatment and Fractures in Men with Hypogonadism. Reply.

Journal: The New England journal of medicine

Published: April 10, 2024

Testosterone Treatment and Fractures in Men with Hypogonadism.

Testosterone Treatment and Fractures in Men with Hypogonadism.

Journal: The New England journal of medicine

Published: January 17, 2024

Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension.

Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension.

Journal: Frontiers in endocrinology

Published: June 07, 2023

Testosterone Treatment of Men with Unequivocal Hypogonadism Following Treatment of Organ-Confined Prostate Cancer.

Testosterone Treatment of Men with Unequivocal Hypogonadism Following Treatment of Organ-Confined Prostate Cancer.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: April 10, 2023

Showing 1-12 of 68

Last Updated: 09/26/2026